Successful At-Home Use of the Tandem Control-IQ Artificial Pancreas System in Young Children During a Randomized Controlled Trial-Reference-Cited by-同舟云学术

Successful At-Home Use of the Tandem Control-IQ Artificial Pancreas System in Young Children During a Randomized Controlled Trial

Published:2019-04 Issue:4 Volume:21 Page:159-169
ISSN:1520-9156
Container-title:Diabetes Technology & Therapeutics
language:en
Short-container-title:Diabetes Technology & Therapeutics

Author:

Forlenza Gregory P.¹,Ekhlaspour Laya²,Breton Marc³,Maahs David M.²,Wadwa R. Paul¹,DeBoer Mark³,Messer Laurel H.¹,Town Marissa²,Pinnata Jennifer³,Kruse Geoff⁴,Buckingham Bruce A.²,Cherñavvsky Daniel³

Affiliation:

1. Barbara Davis Center for Childhood Diabetes, University of Colorado Denver, Aurora, Colorado.

2. Department of Pediatrics, Stanford Diabetes Research Center, Stanford, California.

3. Center for Diabetes Technology, University of Virginia, Charlottesville, Virginia.

4. Tandem Diabetes Care, San Diego, California.

Publisher

Mary Ann Liebert Inc

Subject

Medical Laboratory Technology,Endocrinology,Endocrinology, Diabetes and Metabolism

Link

https://www.liebertpub.com/doi/pdf/10.1089/dia.2019.0011

Reference23 articles.

1. Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis

2. Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials

3. Artificial Pancreas as an Effective and Safe Alternative in Patients with Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis

4. Control to Range for Diabetes: Functionality and Modular Architecture

5. Modular Closed-Loop Control of Diabetes

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diabetes in Childhood;Textbook of Diabetes;2024-01-12

2. Automated Insulin Delivery for Pregnant Women With Type 1 Diabetes: Where do we stand?;Journal of Diabetes Science and Technology;2024-01-10

3. (Hybrid) Closed-Loop Systems: From Announced to Unannounced Exercise;Diabetes Technology & Therapeutics;2023-12-22

4. 7. Diabetes Technology: Standards of Care in Diabetes—2024;Diabetes Care;2023-12-11

5. Challenges of CRISPR/Cas-Based Cell Therapy for Type 1 Diabetes: How Not to Engineer a “Trojan Horse”;International Journal of Molecular Sciences;2023-12-10